NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS back to previous page show list
»07/09/2009 [Industry news]
MOH releases preliminary new National Formulary draft for comment

The Ministry of Health (MOH) issued the draft of the new National Formulary on its website September 3. The MOH has requested experts to submit their opinions and feedback by September 30.

 
The Ministry of Health (MOH) issued the draft of the new National Formulary on its website September 3. The MOH has requested experts to submit their opinions and feedback by September 30. The National Formulary is designed to regulate hospital drug usage and curb prescribing of expensive or unnecessary drugs. The National Formulary details drug treatment plans for 194 types of diseases, as well as symptoms of each disease, indications, contraindications, and adverse reactions of drugs used for treatment. An example of a formulary entry outline: Antineoplastic Drugs General treatment of neoplasms 1) Mechanism and classification of antineoplastic drugs 2) Rational usage of antineoplastic drugs 3) Adverse reactions associated with antineoplastic drugs 4) Development of antineoplastic drugs Treatment plans for tumors 1) NSCLC treatment plans 2) Breast cancer treatment plans 3) Gastrointestinal cancer treatment plans Antitumor drugs 1) Cytototoxic drugs 2) Hormone-type drugs 3) Biological response modification (BRM) drugs 4) Targeted therapies 5) Others

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.